DNA-PCNA dual-staining analysis of bone and soft tissue tumors with flow cytometry

Journal of Orthopaedic Science

Volumn 2, Issue 4, 1997, Pages 203-209

  Asakura, Sachiko ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Bone and soft tissue tumor; Flow cytometry; PCNA

Indexed keywords

CYCLINE; DNA;

ARTICLE; BONE CANCER; BONE TUMOR; CANCER GRADING; CELL CYCLE; CLINICAL ARTICLE; FLOW CYTOMETRY; HISTOGRAM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLOIDY; SOFT TISSUE CANCER; SOFT TISSUE TUMOR;

EID: 0030753472     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02489039     Document Type: Article

References (28)

1. Alho A, Skjeldal S, Pettersen E, et al. Aneuploidy in benign tumors and nonneoplastic lesions of musculoskeletal tissues. Cancer 1994;73:1200-5.
2. Bata-Csorgo Zs, Hammerberg C, Voorhees JJ, et al. Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis. J Exp Med 1993; 178:1271-81.
3. Beppu T, Ishida Y, Arai H, et al Identification of S-phase cells with PClO antibody to proliferating cell nuclear antigen (PCNA) by flow cytometric analysis. J Histochem Cytochem 1994;42:1177-82.
4. Bolton WE, Freeman JW, Mikulka WR, et al. Expression of proliferation-associated antigens (PCNA, p120, p145) during the reentry of G0 cells into the cell cycle. Cytometry 1994;17:66-74.
5. Budach W, Budach V, Socha B, et al. DNA content as a predictor of clinical outcome in soft tissue sarcoma patients. Eur J Cancer 1994;30A:1815-21.
6. Casadai GP, Scheithauer BW, Hirose T, et al. Cellular schwannoma: A clinicopathologic, DNA flow cytometric, and proliferation marker study of 70 patients. Cancer 1995;75:1109-19.
7. Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms J Pathol 1990;162:285-94.
8. Ichikawa A, Shimamura K, Koyama Y. Flow cytometric techniques for measurement of proliferating cell nuclear antigen (PCNA) (in Japanese). Jpn J Clin Med 1992;50:2343-8.
9. Ichikawa A, Shimamura K. PCNA-DNA dual staining and semi-quantitative analysis of PCNA fluorescence intensity in human tumors using a flow cytometer (in Japanese). Cytometry Research 1995;5:63-9.
10. Inoue H, Ogawa J, Shohtsu A. Immunohistochemical expression of p53 in relation to proliferative potential and prognosis in lung cancer (in Japanese). Lung Cancer 1994;34:153-9.
11. Kreicbergs A, Silvferswärd C, Tribukait B. Flow DNA analysis of primary bone tumors: Relationship between cellular DNA content and histopathologic classification. Cancer 1984;53:129-36.
12. Kroese MCS, Rutgers DH, Wils IS, et al. The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors. Cancer 1990;65:1782-8.
13. Ladanyi M, Traganos F, Huvos AG. Benign metastasizing giant cell tumors of bone: A DNA flow cytometric study. Cancer 1989;64:1521-6.
14. Landberg G, Roos G. Flow cytometric analysis of proliferation associated nuclear antigens using washless staining of unfixed cells. Cytometry 1992;13:230-40.
15. Linden MD, Ma CK, Kubus J, et al. Ki-67 and proliferating cell nuclear antigen tumor proliferative indices in DNA diploid colorectal adenocarcinomas: Correlation with histopathologic characteristics and cell cycle analysis with two-color DNA flow cytometry. Am J Clin Pathol 1993;100:206-12.
16. Mathews MB, Bernstein RM, Franza Jr BR, et al. Identity of the proliferating cell nuclear antigen and cyclin. Nature 1984;309:374-6.
17. Matsuno T, Gebhardt MC, Schiller AL, et al. The use of flow cytometry as a diagnostic aid m the management of soft-tissue tumors. J Bone Joint Surg Am 1988;70:751-9.
18. Miyachi K, Fritzler MJ, Tan EM. Autoantibody to a nuclear antigen in proliferating cells. J Immunol 1978;121:2228-34.
19. Oda Y, Hashimoto H, Takeshita S, et al. The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma. Cancer 1993;72:478-85.
20. Oshiro Y, Fukuda T, Tsuneyoshi M. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis: A comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry, and p53. Am J Surg Pathol 1994; 18.712-9.
21. Skeel RT, Lachant NA. Handbook of cancer chemotherapy. 4th ed. Boston: Little, Brown, 1991.
22. Sara AS, Ayala AG, El-Naggar A, et al. Giant cell tumor of bone: A clinicopathologic and DNA flow cytometric analysis Cancer 1990;66:2186-90.
23. Sasaki K, Kurose A, Ishida Y. Flow cytometric analysis of the expression of PCNA during the cell cycle in HeLa cells and effects of the inhibition of DNA synthesis on it. Cytometry 1993;14:876-82.
24. Swanson SA, Brooks JJ. Proliferation markers Ki-67 and p105 in soft tissue lesions: Correlation with DNA flow cytometric characteristics. Am J Pathol 1990;137:1491-500.
25. Teague K, El-Naggar A. Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms. Cytometry 1994;15:21-7.
26. Wenz F, Lohr F, Flentje M. Flow cytometric measurement of proliferating cell nuclear antigen (PCNA) in solid tumors. Strahlenther Onkol 1994;170:235-42.
27. Yu CCW, Hall PA, Fletcher CD, et al. Haemangiopericytomas: The prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA) Histopathology 1991;19:29-33.
28. Zalupski MM, Ryan JR, Ensley JF, et al. Development and optimization of tissue preparative methodology for DNA content analysis of soft tissue neoplasms. Cytometry 1993;14:922-30.